Quality trials and quality of life in non-small-cell lung cancer

Journal of Clinical Oncology

Volumn 21, Issue 16, 2003, Pages 3007-3008

  Harper, Peter ^a   Plunkett, Tim ^a   Khayat, David ^b  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYTOTOXIC AGENT; DEXAMETHASONE; DOCETAXEL; GEMCITABINE; IFOSFAMIDE; MITOMYCIN; NAVELBINE; PACLITAXEL;

ADVANCED CANCER; ANEMIA; AREA UNDER THE CURVE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE COURSE; EDITORIAL; HUMAN; LUNG NON SMALL CELL CANCER; MULTIPLE CYCLE TREATMENT; NAUSEA; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT; VOMITING; WEIGHT REDUCTION; CLINICAL PROTOCOL; FEMALE; LUNG TUMOR; MALE; MORTALITY; NOTE; STANDARD;

ANTINEOPLASTIC PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; QUALITY OF LIFE;

EID: 0042914731     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.05.079     Document Type: Editorial

References (11)

1. Fosella F, Pereira JR, von Pawel J: Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer. J Clin Oncol 21: 3016-3024, 2003
2. American Society of Clinical Oncology: Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. J Clin Oncol 14:671-679, 1996
3. Hollen PJ, Gralla RJ, Kris MG, et al: Quality of life assessment in individuals with lung cancer: Testing the Lung Cancer Symptom Scale (LCSS). Eur J Cancer 29A:S51-S58, 1993
4. Brooks R: EuroQol: The current state of play. Health Policy 37:53-72, 1996
5. Aaronson NK: Assessing the quality of life of patients in cancer clinical trials: Common problems and common sense solutions. Eur J Cancer 28A:1304-1307, 1992
6. Herndon JE II, Fleishman S, Kosty MP, et al: A longitudinal study of quality of life in advanced non-small cell lung cancer: Cancer and Leukemia Group B (CALGB) 8931. Control Clin Trials 18:286-300, 1997
7. Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer: The Elderly Lung Cancer Vinorelbine Italian Study Group. J Natl Cancer Inst 91:66-72, 1999
8. Kelly K, Crowley J, Bunn PA Jr, et al: Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: A Southwest Oncology Group trial. J Clin Oncol 19:3210-3218, 2001
9. Scagliotti GV, De Marinis F, Rinaldi M, et al: Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer. J Clin Oncol 20:4285-4291, 2002
10. Schiller JH, Harrington D, Belani CP, et al: Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346:92-98, 2002
11. Rudd RM, Gower NH, James LH, et al: Phase III randomized comparison of gemcitabine and carboplatin (GC) with mitomycin, ifosfamide and cisplatin (MIP) in advanced non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 21:292a, 2002 (abstr 1164)